Skip to content

Spembly 9000 & 9300

by Spembly Medical, Ltd.

510(k) K802063

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK802063 Date3 Oct 1980ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
GZJ
FDA applicant
Spembly Medical , Ltd.
Device Class
Class II
Regulation
21 CFR Part 882.5890
Advisory Committee
Neurology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Spembly 9000 & 9300 are electrosurgical devices designed for neurosurgical procedures, specifically intended for brain tissue coagulation and cutting. These instruments utilize high-frequency electrical current to achieve precise tissue manipulation, aiding in surgical interventions within the neurological field.

These devices are supplied as reusable medical instruments and are classified under FDA product code GZJ, with clearance granted under the 510(k) pathway. They were authorized for use in the United States on October 3, 1980, following a review by the Neurology Advisory Committee. No additional sterility or MRI safety specifications are noted in the regulatory data.

Other devices from Spembly Medical, Ltd.

See all devices from Spembly Medical, Ltd. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are the Spembly 9000 & 9300 devices intended for single-use or can they be reused in multiple procedures?

    The Spembly 9000 & 9300 are explicitly described as reusable medical instruments, meaning they are designed for repeated use after proper cleaning, sterilization, and maintenance between procedures. This classification aligns with their regulatory submission under the FDA’s 510(k) pathway, where reusable electrosurgical tools are standard.

  • What types of neurosurgical procedures are these devices primarily used for?

    The Spembly 9000 & 9300 are specifically designed for brain tissue coagulation and cutting during neurosurgical procedures. Their high-frequency electrical current enables precise manipulation of neurological tissue, making them suitable for interventions within the brain. The device’s intended use is reflected in its FDA clearance under the Neurology Advisory Committee review.

  • How are these devices supplied, and do they come in multiple sizes or models?

    The data provided does not specify individual sizes or models beyond the 9000 and 9300 series, which are two distinct electrosurgical instruments. Both are supplied as reusable instruments, but exact variations (e.g., blade shapes, tip designs, or handle configurations) are not detailed in the regulatory submission. For precise sizing or model-specific features, consult the manufacturer’s technical documentation.

  • Are there any special storage requirements for these reusable electrosurgical devices?

    While the regulatory data does not explicitly outline storage instructions, reusable electrosurgical instruments like the Spembly 9000 & 9300 typically require clean, dry, and protected environments to prevent damage or contamination. Proper storage should follow manufacturer guidelines for electrosurgical tools, including avoiding exposure to moisture, extreme temperatures, or physical stress. Always refer to Spembly Medical’s operational manual for device-specific storage recommendations.

  • What was the regulatory pathway and timeline for FDA clearance of these devices?

    The Spembly 9000 & 9300 were cleared via the FDA’s 510(k) pathway, determined to be substantially equivalent to a predicate device. The submission was received on August 26, 1980, and reviewed by the Neurology Advisory Committee (NE), leading to clearance on October 3, 1980. The clearance type was Traditional, and the product code assigned was GZJ, categorizing them under electrosurgical instruments for neurosurgery.